ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,040.00
      -0.96%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.64
      -0.17%
      Bitcoin
      66,185.43
      0.40%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Solvay SA (SOLB) Quote

      Solvay SA

      Solvay SA (SOLB)

      Solvay SA
      33.59
      -0.24
      ( -0.71% )
      Updated: 04:12:12
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      33.59
      Bid
      33.57
      Ask
      33.60
      Volume
      9,537
      33.46 Day's Range 33.75
      17.895 52 Week Range 113.05
      Market Cap
      3.556B
      Previous Close
      33.83
      Open
      33.55
      Last Trade
      86
      @
      33.59
      Last Trade Time
      04:11:56
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      306,008
      Shares Outstanding
      105,876,000
      Dividend Yield
      -
      PE Ratio
      1.70
      Earnings Per Share (EPS)
      19.77
      Revenue
      11.37B
      Net Profit
      2.09B

      About Solvay SA

      Sector
      Chems, Allied Pds-whsl, Nec
      Industry
      Plastics,resins,elastomers
      Website
      www.solvay.com
      Headquarters
      Brussels, Brussels-capital Region, Bel
      Founded
      1863
      Solvay SA is listed in the Chems, Allied Pds-whsl sector of the Euronext with ticker SOLB. The last closing price for Solvay was 33.83 €. Over the last year, Solvay shares have traded in a share price range of 17.895 € to 113.05 €.

      Solvay currently has 105,876,000 shares outstanding. The market capitalization of Solvay is 3.58 € billion. Solvay has a price to earnings ratio (PE ratio) of 1.70.

      SOLB Latest News

      More News

      Solvay reports share buyback in the context of its Employee Share Purchase Plan and long-term incentive plans

      Solvay reports share buyback in the context of its Employee Share Purchase Plan and long-term incentive plans Brussels, June 26, 2024, 5:45pm CEST  -  Regulated information In accordance...

      June 26 2024
      GlobeNewswire Inc.

      Solvay showcases the leadership positions, strong cash generation and growth prospects of its Performance Chemicals business

      Solvay showcases the leadership positions, strong cash generation and growth prospects of its Performance Chemicals business Solvay held a webinar for the investment community on its...

      June 25 2024
      GlobeNewswire Inc.

      Solvay and Cyclic Materials sign supply agreement for recycled mixed rare earth oxide (EN / FR)

      Solvay and Cyclic Materials sign supply agreement for recycled mixed rare earth oxide (EN / FR) Press release Communiqué de presse   Solvay and Cyclic Materials sign supply agreement for...

      June 18 2024
      GlobeNewswire Inc.

      Notifications de participation par BNP Paribas Asset Management SA

      Notifications de participation par BNP Paribas Asset Management SA Bruxelles, le 10 juin 2024 - 17h45 CEST  -  Information réglementée Conformément à la législation et réglementation en...

      June 10 2024
      GlobeNewswire Inc.

      Participation notifications by BNP Paribas Asset Management SA

      Participation notifications by BNP Paribas Asset Management SA Brussels, June 10, 2024, 17:45 CEST  -  regulated information In line with Belgian transparency legislation (Law of May 2...

      June 10 2024
      GlobeNewswire Inc.

      Outcome of the 2024 Shareholders’ Meeting

      Outcome of the 2024 Shareholders’ Meeting All resolutions were endorsed by shareholders Brussels, May 28, 2024 - 5.45pm CEST – regulated information Solvay held its Ordinary General...

      May 28 2024
      GlobeNewswire Inc.

      Résultats du premier trimestre 2024

      Résultats du premier trimestre 2024 Information réglementée Un FCF solide soutenu par un EBITDA résilient et la gestion maîtrisée des coûts et des investissements Bruxelles, le 7 mai 2024 à...

      May 07 2024
      GlobeNewswire Inc.

      Participation notification by UBS Group AG

      Participation notification by UBS Group AG Brussels, April 29, 2024, 08:30 CEST - Regulated information In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG...

      April 29 2024
      GlobeNewswire Inc.

      Solvay publie la convocation à son Assemblée Générale annuelle de 2024

      Solvay publie la convocation à son Assemblée Générale annuelle de 2024 Bruxelles, le 26 avril 2024 - 8h00 CEST  -  information réglementée Solvay annonce la publication des documents relatifs...

      April 26 2024
      GlobeNewswire Inc.

      Solvay publishes notice of 2024 Annual General Meeting

      Solvay publishes notice of 2024 Annual General Meeting Brussels, April 26, 2024, 8:00am CEST - regulated information Solvay today published materials for its next Ordinary General...

      April 26 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.862.6275588145432.7334.9332.0421112534.23526144DE
      41.695.2978056426331.934.9331.6520024633.29835373DE
      123.1810.457086484730.4136.6229.530600832.91032312DE
      267.9931.210937525.636.6222.2140567928.18467052DE
      52-69.61-67.4515503876103.2113.0517.89539354139.62525504DE
      156-76.86-69.5880488909110.45118.6517.89526061967.7989641DE
      260-61.51-64.679284963295.1118.6517.89525862174.99180198DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NUZENuZee Inc
      $ 2.22
      (115.53%)
      		330.52k
      ALLRAllarity Therapeutics Inc
      $ 0.2938
      (76.46%)
      		2.89M
      NIVFNewGenIvf Group Ltd
      $ 1.21
      (38.94%)
      		164.55k
      DRMADermata Therapeutics Inc
      $ 1.76
      (35.38%)
      		308
      RGCRegencell Bioscience Holdings Ltd
      $ 19.99
      (33.62%)
      		3.61k
      CONNConns Inc
      $ 0.3085
      (-39.15%)
      		24.04k
      VSTMVerastem Inc
      $ 2.84
      (-20.89%)
      		1.25k
      SLRXSalarius Pharmaceuticals Inc
      $ 2.10
      (-19.54%)
      		2.64k
      CJETChijet Motor Company Inc
      $ 4.20
      (-17.32%)
      		218
      ALPPAlpine 4 Holdings Inc
      $ 0.505
      (-15.82%)
      		6.7k
      ALLRAllarity Therapeutics Inc
      $ 0.2989
      (79.52%)
      		2.9M
      SLNASelina Hospitality PLC
      $ 0.0298
      (14.62%)
      		922.81k
      NUZENuZee Inc
      $ 2.21
      (114.56%)
      		331.37k
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 11.56
      (-15.62%)
      		216.48k
      TSLATesla Inc
      $ 227.32
      (-7.74%)
      		170.47k

      Discussion

      View Full Feed
      Margin Buu Margin Buu 5 minutes ago
      One of the biggest FUD tactics has been around the timeframe of this approval. There have been 1000 posts by nefarious actors just trying to convince us that the 150-day review pathway (requested by the company) was in business days when the review clock has always been CALENDAR DAYS. Not only is t
      NWBO
      chicks0123 chicks0123 7 minutes ago
      Good morning CLNVERS
      CLNV
      urge2surge urge2surge 8 minutes ago
      Copied and posted word for word.
      FDCT
      dirkv dirkv 10 minutes ago
      Theravet (BE0974387194) Euronext Growth Paris et Bruxelles : 0.278
      52w: 0.278 – 2.4
      https://www.thera.vet/en/home

      https://www.theravet-finances.com/images/202404_Theravet_Company_Presentation_Competition_Sport_Horses.pdf

      their products:
      https://bioc
      dirkv dirkv 10 minutes ago
      Theravet (BE0974387194) Euronext Growth Paris et Bruxelles : 0.278
      52w: 0.278 – 2.4
      https://www.thera.vet/en/home

      https://www.theravet-finances.com/images/202404_Theravet_Company_Presentation_Competition_Sport_Horses.pdf

      their products:
      https://bioc
      manfromjax manfromjax 12 minutes ago
      WOW, am I going to be happy that I picked up 2000 more shares of ALLR at .17!!!
      average is now .32.
      Was up to .30 as I sit here in Riga Latvia.
      ALLR
      ShadowDiviner72 ShadowDiviner72 13 minutes ago
      Shorts can say whatever they want, but why is the cost to borrow fee decreasing rapidly?

      In 10 trading days from 96% to 9%

      Apparently the demand for short shares is decreasing quickly
      MAXN
      MrLWLG101 MrLWLG101 15 minutes ago
      The news about the appointment of Yves LeMaitre, a renowned and respected figure in the industry and business, acts as a magnet for short-sellers. I see this more in terms of "defamation and slander" against him and the entire BOD of LWLG, without thorough reasons and evidence. The moderators should
      LWLG
      SkeBallLarry SkeBallLarry 16 minutes ago
      Graceland (from The Concert in Hyde Park >

      https://youtu.be/0VTcBO4q5kY
      SkeBallLarry SkeBallLarry 17 minutes ago
      Graceland (from The Concert in Hyde Park >

      https://youtu.be/0VTcBO4q5kY
      SkeBallLarry SkeBallLarry 17 minutes ago
      BreakTime ~ Graceland (from The Concert in Hyde Park >

      https://youtu.be/0VTcBO4q5kY
      palaypu0406 palaypu0406 18 minutes ago
      whenever large wires that too international wires transfer in, or anytime if there is a larger inward (even domestic) with regular balances not anywhere near to the size of the funds coming in, bank does keep the funds on hold and release within the defined date.
      ITUP
      1hunglo 1hunglo 20 minutes ago
      AGREED.
      RDGL
      palaypu0406 palaypu0406 21 minutes ago
      Dear Snow and all (I am addressing Snow first as he is the eldest among the group),
      I am very happy to share that we have money availability on the 7/29/2024) -- This is one year of burn -- facing so many challenges, insults, humiliation and spits on face. Despite that - we never let our spi
      ITUP
      Margin Buu Margin Buu 26 minutes ago
      Thanks for pointing out Leg-ends hypocrisy. He’s a spreader of FUD and not very good at it.
      NWBO
      Jack Torrance Jack Torrance 28 minutes ago
      I personally think 80%.
      MNMD
      CaptainObvious CaptainObvious 33 minutes ago
      "The reality about this stock is nobody knows anything....

      ...something I will bet a lot on is that the stock will not get above $1"
      NWBO
      Capt_Smith77 Capt_Smith77 56 minutes ago
      I'll believe in their backing of G42 when it doesn't amount to diluting shareholders, and there's an actual appreciation in the stock price. To date, the company's financing has done nothing but reduce shareholder value.

      Now on a more positive note, at least we haven't seen any recen
      VRSSF
      tedgoeseast tedgoeseast 1 hour ago
      Everyone else has already seen this on the news today it's nothing new
      Sonar Sonar 1 hour ago
      The only document related to Mr Norward and Oceanwide Plaza:
      https://www.myvisajobs.com/Visa-Sponsor/Tohigh-Construction-Investment/1236463.htm
      Relationship between Mr Norward and ESSGCorp.net
      https://investorshub.advfn.com/uimage/uploads/2024/7/24/wzxfcScreenshot_2024-07-24_094
      JBZY
      Capt_Smith77 Capt_Smith77 1 hour ago
      Of course they're not still testing the software. At least not anyone but maybe Blue Yonder, which was the last one to join the Beta program, IIRC.

      Still, the company has advertised them all as partnerships, which they are not. They've even reworded how things are said in recent PRs
      VRSSF

      Your Recent History

      EU
      SOLB
      Solvay
      LSE
      PM87
      Citi Fun 25
      COIN
      SHIHUSD
      Shih Tzu
      BIT
      UC7C6R
      Unicredit Bank
      Delayed Upgrade Clock